查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1935646

全螺紋縫合錨釘市場（按錨釘類型、材料、應用和最終用戶分類），全球預測（2026-2032）

Fully Threaded Suture Anchor Market by Anchor Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年全螺紋縫合錨釘市場價值為 7.093 億美元，預計到 2026 年將成長至 7.664 億美元，年複合成長率為 8.07%，到 2032 年將達到 12.2145 億美元。

關鍵市場統計數據
基準年 2025 7.093億美元
預計年份：2026年 7.664億美元
預測年份 2032 12.2145億美元
複合年成長率 (%) 8.07%

這是一個清晰且有臨床依據的關於全螺紋縫合錨釘的介紹，解釋了為什麼在醫療保健系統中，植入設計與臨床工作流程的一致性至關重要。

全螺紋縫合錨釘已成為肩關節修復手術的關鍵技術，可提供牢固的組織固定並提高關節鏡的效率。這些裝置常用於關節唇和肩迴旋肌修復，其機械可靠性和易於植入的特性直接影響手術效果和術後復健。隨著手術技術向微創方向發展，錨釘的設計、材料選擇和植入機制在臨床應用和採購決策中發揮越來越重要的作用。

變革性變化正在重塑全螺紋縫合錨釘的臨床、技術和商業性格局

由於臨床、技術和報銷方面的協同效應，全螺紋縫合錨釘的市場格局正在發生顯著變革時期。在臨床方面，關節鏡手術技術的不斷改進以及對基於價值的治療結果日益重視，促使外科醫生和採購團隊優先選擇能夠在退化性和創傷性組織中提供可靠固定，同時又能降低手術複雜性的錨釘。因此，設計創新正著重於縫線管理、簡化的無結植入方案以及無需額外手術步驟即可適應多種骨骼類型的結構。

分析2025年美國關稅對植入製造商的採購、製造、定價趨勢及供應鏈風險的影響

美國於2025年實施的一系列關稅措施，立即增加了全螺紋縫合錨釘領域製造商和醫療器材採購商的營運複雜性。這些措施影響了零件的成本結構，尤其是那些依賴國際原料和海外製造組裝的企業。進口關稅提高了某些投入品的到岸成本，迫使製造商決定是否自行承擔額外成本、與供應商重新談判條款，或重新設計供應鏈以降低風險。

關鍵細分分析揭示了使用者偏好、材料權衡以及按錨點類型、材料、應用和臨床環境分類的臨床應用案例。

細分市場分析揭示了影響臨床選擇和商業化策略的產品和採購趨勢的顯著差異。在錨釘類型方面，無結錨釘在需要快速縫合和縮短手術時間的情況下越來越受歡迎。然而，當某些外科醫生優先考慮對張力和固定的絕對控制時，有結錨釘仍然有用。這些偏好因醫療機構和外科醫生群體而異，無結錨釘通常因其工作流程優勢而更具吸引力，而有結錨釘則往往在複雜修復中提供更大的靈活性。

區域觀點，重點分析美洲、歐洲、中東和非洲以及亞太地區的縫合錨釘採用模式、法規環境和成長促進因素

區域趨勢將顯著影響全螺紋縫合錨釘的研發、監管和應用進展。在美洲，高手術量、強大的公立和私人醫療保險體係以及對循證採購的重視共同推動了臨床應用。該地區的醫生往往需要可靠的臨床數據和簡化的器械，而供應商則需要在競爭激烈的市場環境中應對，服務、培訓和分銷商關係在其中發揮著至關重要的作用。該地區的監管路徑，尤其注重上市後監測和明確的醫療設備分類，正在影響新產品的上市速度。

深入分析全螺紋縫合錨市場主要企業的創新促進因素、差異化策略和競爭定位

全螺紋縫合錨釘領域的競爭地位取決於產品創新、臨床證據累積和市場推廣執行三者之間的平衡。主要企業透過改進輸送系統、材料科學和臨床醫生支援計劃來脫穎而出。能夠縮短手術時間、簡化縫線管理並實現與現有器械相容的創新正獲得常用用戶的強力支援。投資於外科醫生培訓、專用手術包和真實臨床數據收集的企業通常能在醫療機構的競標中更快獲得支援。

針對希望加強市場地位、降低供應鏈風險並加速全螺紋縫合錨釘臨床應用的行業領導者的具體建議

產業領導者應優先考慮制定一套連貫的策略，將產品開發、臨床證據產生和供應鏈韌性聯繫起來。首先，將設計重點與外科醫生的工作流程相匹配——例如改進縫合線管理、降低器械複雜性以及確保與常用錨釘相容——將加速臨床應用並簡化採購決策。透過可靠的臨床研究和真實世界註冊研究來補充這些產品改進，將建立引人注目的價值提案，並支持產品被納入醫療機構的處方集。

調查方法概述了用於綜合全螺紋縫合錨釘知識的資料來源、分析方法、三角測量技術和檢驗通訊協定。

為了確保研究途徑的嚴謹性和相關性，我們採用了多方法架構。主要研究包括對骨科醫生、採購主管和供應鏈經理進行深度訪談，以獲取關於臨床需求、器械偏好和採購行為的第一手資訊。這些定性見解輔以監管指南、臨床文獻和手術操作規範的二手研究，從而建立器械應用案例和材料選擇的客觀標準。

總之，我們總結了臨床醫生、製造商和醫療保健負責人在應對全螺紋縫合錨釘環境時所面臨的戰略意義。

全螺紋縫合錨釘領域正處於轉折點，其特點是材料創新、技術改進以及對產品價值日益嚴格的商業性考慮。臨床醫生越來越需要能夠無縫整合到關節鏡流程中，並在各種組織類型中提供可靠機械性能的錨釘。那些透過迭代設計改進、循證推廣和以外科醫生為中心的培訓計畫來滿足需求的製造商，將更有利於在門診和住院環境中獲得廣泛應用。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 全螺紋縫合錨釘市場（按錨釘類型分類）

  • 沒有繩結
  • 存在結節

9. 全螺紋縫合錨釘市場（依材料分類）

  • 可生物分解聚合物
  • PEEK（聚醚醚酮）
  • 不銹鋼
  • 鈦

第10章 全螺紋縫合錨釘市場依應用領域分類

  • 關節唇修復
  • 肩迴旋肌修復

第11章 全螺紋縫合錨釘市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
    • 大學醫院
    • 社區醫院
  • 專科診所

第12章 全螺紋縫合錨釘市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 全螺紋縫合錨釘市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國全螺紋縫合錨釘市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國全螺紋縫合錨釘市場

第16章 中國全螺紋縫合錨釘市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acumed, LLC
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • B. Braun AG
  • Bioventus
  • CONMED Corporation
  • Enovis Corporation
  • Johnson & Johnson Services, Inc.
  • Keyi Bangen
  • LimaCorporate
  • Medos International
  • Medtronic plc
  • MJ Surgical
  • Orthofix Medical Inc.
  • Ossio, Inc.
  • Parcus Medical LLC
  • Rejoin Medical Device Co., Ltd.
  • RTI Surgical, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Tokyo Ohka Kogyo Co., Ltd.
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-9A6A6F29744C

The Fully Threaded Suture Anchor Market was valued at USD 709.30 million in 2025 and is projected to grow to USD 766.40 million in 2026, with a CAGR of 8.07%, reaching USD 1,221.45 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 709.30 million
Estimated Year [2026] USD 766.40 million
Forecast Year [2032] USD 1,221.45 million
CAGR (%) 8.07%

A clear, clinically grounded introduction to fully threaded suture anchors explaining why implant design and clinical workflow alignment matter for healthcare systems

Fully threaded suture anchors have emerged as a critical technology in shoulder repair procedures, offering secure tissue fixation and streamlined arthroscopic workflows. The devices are frequently used in labral and rotator cuff repairs, where mechanical reliability and ease of deployment directly influence surgical outcomes and postoperative rehabilitation pathways. As surgical techniques evolve toward minimally invasive approaches, anchor design, material selection, and deployment mechanisms play increasingly prominent roles in shaping clinical adoption and procurement choices.

Clinicians seek implants that reduce operative time, lower the risk of anchor-related complications, and deliver reproducible fixation strength across diverse tissue qualities. Concurrently, hospital systems and ambulatory surgical centers prioritize devices that support predictable throughput, cost containment, and durable clinical outcomes that minimize readmissions and revision procedures. These dual imperatives-clinical performance and system-level efficiency-define the competitive landscape for fully threaded suture anchors.

Innovation in materials and construct design has broadened the set of trade-offs available to device developers, enabling combinations that balance resorbability, radiolucency, and long-term mechanical integrity. The interplay among anchor geometry, suture management strategies, and delivery instrumentation continues to influence user preference and procurement frameworks. Looking ahead, alignment between product development and the operational needs of end users will determine which solutions translate into sustained adoption across care settings.

Transformative shifts reshaping the clinical, technological, and commercial landscape for fully threaded suture anchors

The landscape for fully threaded suture anchors is undergoing a period of meaningful transformation driven by converging clinical, technological, and reimbursement dynamics. On the clinical front, the steady refinement of arthroscopic techniques and growing emphasis on value-based outcomes have pushed surgeons and procurement teams to favor anchors that reduce procedure complexity while delivering reliable fixation in both degenerative and traumatic tissue contexts. As a result, design innovation has prioritized suture management, streamlined knotless deployment options, and constructs that accommodate variable bone quality without adding surgical steps.

Technological momentum centers on material science and device integration. Advances in polymer formulation and bioresorbable composites are enabling implants that maintain early mechanical security and then gradually transfer load to healing tissues, potentially reducing imaging artifacts and facilitating follow-up evaluations. Simultaneously, high-performance non-resorbable options such as PEEK and titanium remain essential where long-term mechanical durability and radiographic clarity are prioritized. The desire to reconcile these competing requirements has spurred iterative improvements in anchor geometry and thread profiles that enhance pullout resistance while minimizing bone disruption.

Commercially, procurement strategies are shifting as providers place greater emphasis on total episode value rather than unit price alone. Value-based purchasing and bundled payment paradigms encourage closer collaboration among device manufacturers, surgical teams, and supply chain managers to demonstrate reproducible outcomes, predictable inventories, and instrumentation compatibility. This has amplified the importance of evidence generation-clinical registries, head-to-head comparative studies, and real-world outcomes data-to substantiate claims of improved efficiency or reduced complications. Taken together, these shifts are catalyzing a market environment in which clinical differentiation, supply chain responsiveness, and evidence-backed value propositions determine long-term success.

Analysis of how United States tariffs implemented in 2025 influenced sourcing, manufacturing, pricing dynamics, and supply chain risk for implant manufacturers

The set of tariff measures introduced in the United States in 2025 introduced an immediate layer of complexity for manufacturers and healthcare purchasers operating in the fully threaded suture anchor space. These measures affected the cost structure of components, particularly for companies that relied on internationally sourced raw materials or overseas manufacturing and assembly. As import duties raised landed costs for certain inputs, manufacturers faced decisions about whether to absorb additional expenses, renegotiate supplier terms, or redesign supply chains to mitigate exposure.

In response, several strategic adjustments became more common. Some device makers accelerated nearshoring efforts or consolidated suppliers to secure more predictable pricing and lead times. Others initiated product redesigns to substitute materials with locally available alternatives where clinically acceptable, or to simplify the bill of materials and reduce the number of imported subcomponents. These tactical shifts aimed to preserve competitive pricing while maintaining clinical performance, yet they required targeted investments in validation and regulatory documentation to ensure continued product compliance and safety.

The tariffs also influenced commercial discussions between manufacturers and healthcare providers. Contract negotiations increasingly incorporated clauses addressing tariff pass-through, inventory hedging strategies, and longer-term supply commitments to offset volatility. Procurement teams adjusted tendering timelines and inventory strategies, balancing the risk of short-term cost increases against the operational imperative to avoid procedural disruptions. For some manufacturers, the cumulative effect prompted reassessment of global manufacturing footprints, prioritizing locations with favorable trade treatments and stable logistics.

Ultimately, the tariffs underscored the importance of supply chain resilience and strategic sourcing in a constrained trade environment. Firms that proactively diversified supplier bases, invested in local validation capabilities, and transparently communicated tariff-related impacts to customers were better positioned to protect margins and sustain market access, while others faced elevated cost pressures that constrained commercial flexibility.

Key segmentation insights that illuminate user preferences, material trade-offs, and clinical use cases across anchor types, materials, applications, and care settings

Segmentation analysis reveals distinct product and procurement dynamics that shape clinical choice and commercialization strategies. When anchors are compared by anchor type, knotless designs are increasingly favored in contexts where rapid suture management and shorter operative times are valued, and knotted anchors retain relevance where absolute control of tension and fixation is prioritized by certain surgeons. These preferences manifest differently across institutions and surgeon cohorts, with knotless solutions often marketed for their workflow advantages and knotted options emphasized for perceived versatility in complex repairs.

Material segmentation exposes the nuanced trade-offs among biodegradable polymers, PEEK, stainless steel, and titanium. Biodegradable polymers appeal to clinicians concerned about long-term implant remnants and imaging interference, though they require careful consideration of early mechanical retention and predictable resorption profiles. PEEK delivers radiolucency and favorable biomechanical characteristics, while stainless steel and titanium preserve long-term mechanical integrity and are frequently selected in cases where permanent support is clinically indicated. The selection process hinges on the interplay of clinical indication, imaging needs, and surgeon comfort with material handling.

Application-based segmentation highlights differences between labral repair and rotator cuff repair usage patterns. Labral repairs often prioritize anchors that facilitate precise suture placement in constrained spaces and that accommodate soft-tissue reattachment with minimal bone removal. Rotator cuff repairs, in contrast, demand constructs that balance pullout resistance with tendon-to-bone compression mechanics, as well as implantation systems that support robust footprint restoration. These divergent application demands inform product design choices and procedural training priorities.

End user segmentation-spanning ambulatory surgical centers, hospitals, and specialty clinics-reveals how care setting influences procurement and product adoption. Ambulatory surgical centers typically emphasize devices that enable rapid turnover and predictable inventory usage. Hospitals, further distinguished into academic and community settings, bring varying priorities: academic hospitals often focus on device flexibility that supports research and complex cases, while community hospitals weigh cost-effectiveness and standardization to manage volumes and budgets. Specialty clinics concentrate on procedural efficiency and surgeon familiarity, influencing the selection of anchor constructs and instrumentation that align with practice patterns.

Regional perspectives that highlight adoption patterns, regulatory contexts, and growth enablers across the Americas, EMEA, and Asia-Pacific markets for suture anchors

Regional dynamics materially influence how fully threaded suture anchors are developed, regulated, and adopted. In the Americas, clinical adoption tends to be driven by a combination of high procedural volumes, robust private and public payer mechanisms, and an emphasis on evidence-based procurement. Surgeons in the region often demand strong clinical data and streamlined instrumentation, and suppliers navigate a competitive environment where service, training, and distributor relationships play decisive roles. Regulatory pathways in the region emphasize post-market surveillance and clear device classifications, shaping the cadence of new product introductions.

Europe, the Middle East & Africa presents a heterogeneous landscape where regulatory harmonization initiatives coexist with country-level procurement idiosyncrasies. Reimbursement frameworks vary widely, prompting manufacturers to craft tailored value propositions that account for differential macroeconomic conditions and hospital purchasing cycles. Clinical practice patterns also reflect regional training emphases and public versus private care mixes, which in turn affect the relative appeal of certain anchor types and materials. Market entry strategies must therefore balance centralized regulatory approaches with local commercial partnerships.

Asia-Pacific is characterized by rapid adoption in selected markets, an increasing focus on orthopaedic procedural capacity building, and diverse regulatory environments that range from highly structured approval regimes to more emergent frameworks. Demand drivers in the region include rising access to specialized surgical care, growing investments in ambulatory surgical infrastructure, and an emphasis on cost-conscious innovation. Manufacturers targeting this region often tailor product breadth and pricing strategies to accommodate varied payer landscapes and surgeon training needs. Across all regions, cross-border collaborations, local clinical evidence generation, and targeted training programs remain essential to secure sustained uptake.

Insights on key companies driving innovation, differentiation strategies, and competitive positioning within the fully threaded suture anchor ecosystem

Competitive positioning in the fully threaded suture anchor space balances product innovation, clinical evidence generation, and go-to-market execution. Leading companies are differentiating through improvements in delivery systems, material science, and clinician support programs. Innovations that reduce procedure time, simplify suture management, and offer compatibility with established instrumentation pathways tend to resonate strongly with high-volume users. Firms that invest in surgeon training, procedure-specific kits, and real-world evidence collection typically gain more rapid traction in institutional tenders.

Strategic partnerships and targeted acquisitions are common tactics to broaden portfolios and accelerate access to complementary technologies such as suture management systems, biologic augmentation, and advanced imaging-compatible materials. Companies that can demonstrate reproducible outcomes through peer-reviewed studies, registry data, and surgeon-led publications often find it easier to secure formulary inclusion and to justify premium positioning where warranted by clinical performance.

Operational excellence in manufacturing and supply chain reliability also serves as a competitive differentiator. Firms that maintain tight quality systems, streamlined logistics, and transparent inventory practices reduce operational risk for healthcare providers and foster long-term procurement relationships. Finally, pricing strategy remains a lever-some companies pursue volume-based models with standardized kits to compete on total episode value, while others focus on differentiated features and premium services to defend higher price points. The ability to align product, evidence, and commercial execution defines leadership in this sector.

Actionable recommendations for industry leaders seeking to strengthen market position, de-risk supply chains, and accelerate clinical adoption of fully threaded suture anchors

Industry leaders should prioritize a coherent strategy that links product development, clinical evidence generation, and supply chain resilience. First, aligning design priorities with surgeon workflow-such as improving suture management, reducing instrumentation complexity, and ensuring compatibility with commonly used anchors-will accelerate clinical adoption and ease procurement decisions. Complementing these product improvements with robust clinical studies and real-world registries will create a defensible value narrative and support inclusion in institutional formularies.

Second, supply chain diversification is essential to withstand trade policy fluctuations and component scarcity. Establishing multi-source procurement strategies, nearshoring critical manufacturing steps where feasible, and maintaining validated secondary suppliers can materially reduce exposure to tariff- and logistics-related disruptions. Transparent communication with customers about sourcing strategies and inventory practices builds trust and supports longer-term contracting arrangements.

Third, manufacturers should invest in tailored commercial models that reflect end user needs across ambulatory surgical centers, hospitals, and specialty clinics. Offering flexible contracting options, training bundles, and clinical support services helps drive adoption in both high-throughput ambulatory settings and complex academic centers. Finally, targeted regional strategies that incorporate local regulatory expertise, evidence generation partnerships, and distributor selection will enable more efficient market entry and sustained growth across diverse geographies.

Research methodology outlining data sources, analytical approaches, triangulation techniques, and validation protocols employed in synthesizing the fully threaded suture anchor intelligence

The research approach combined a multi-method framework to ensure rigor and relevance. Primary research included in-depth interviews with orthopaedic surgeons, procurement leaders, and supply chain managers to capture first-hand perspectives on clinical needs, device preferences, and purchasing behaviors. These qualitative inputs were complemented by secondary research into regulatory guidance, clinical literature, and procedural practice standards to establish an objective baseline of device use cases and material considerations.

Analytical methods emphasized triangulation and cross-validation. Insights from clinical interviews were tested against published peer-reviewed studies and regulatory documentation to confirm safety and performance themes. Supply chain analysis drew upon industry logistics reports and trade policy summaries to assess risk exposure, while competitive intelligence was built from company disclosures, product literature, and conference presentations to map differentiation strategies and capability gaps.

Validation protocols included expert review panels consisting of practising surgeons and hospital procurement specialists who reviewed preliminary findings and provided feedback on clinical relevance and commercial practicability. Where appropriate, technical claims and material performance assertions were cross-checked against biomechanical studies and device instructions for use to ensure factual accuracy. This layered methodology supports robust conclusions while acknowledging the evolving nature of clinical practice and regulatory environments.

Conclusion synthesizing strategic implications for clinicians, manufacturers, and healthcare buyers navigating the fully threaded suture anchor environment

The fully threaded suture anchor domain is at an inflection point characterized by material innovation, procedural refinement, and heightened commercial scrutiny around value. Clinicians increasingly demand anchors that integrate seamlessly into arthroscopic workflows while delivering dependable mechanical performance across a range of tissue qualities. Manufacturers that respond with thoughtful design iteration, evidence-driven claims, and surgeon-centric training programs will be better positioned to secure adoption in both ambulatory and hospital environments.

Supply chain resilience and adaptable sourcing strategies have become central to commercial viability, particularly in the face of trade policy variability and component market fluctuations. Transparent engagement with customers about sourcing, inventory management, and price stability builds trust and reduces negotiation friction. Moreover, regional strategies that reflect regulatory nuances and local clinical practices will be critical to scaling successfully across distinct geographies.

In aggregate, market participants that unite clear clinical differentiation, operational reliability, and credible evidence generation can convert technological advantages into sustainable commercial outcomes. The path forward rewards integrated approaches that align product capabilities with the workflows and priorities of surgeons, procurement teams, and institutional stakeholders.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fully Threaded Suture Anchor Market, by Anchor Type

  • 8.1. Knotless
  • 8.2. Knotted

9. Fully Threaded Suture Anchor Market, by Material

  • 9.1. Biodegradable Polymers
  • 9.2. PEEK (Polyether Ether Ketone)
  • 9.3. Stainless Steel
  • 9.4. Titanium

10. Fully Threaded Suture Anchor Market, by Application

  • 10.1. Labral Repair
  • 10.2. Rotator Cuff Repair

11. Fully Threaded Suture Anchor Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
    • 11.2.1. Academic Hospitals
    • 11.2.2. Community Hospitals
  • 11.3. Specialty Clinics

12. Fully Threaded Suture Anchor Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Fully Threaded Suture Anchor Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Fully Threaded Suture Anchor Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Fully Threaded Suture Anchor Market

16. China Fully Threaded Suture Anchor Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Acumed, LLC
  • 17.6. Anika Therapeutics, Inc.
  • 17.7. Arthrex, Inc.
  • 17.8. B. Braun AG
  • 17.9. Bioventus
  • 17.10. CONMED Corporation
  • 17.11. Enovis Corporation
  • 17.12. Johnson & Johnson Services, Inc.
  • 17.13. Keyi Bangen
  • 17.14. LimaCorporate
  • 17.15. Medos International
  • 17.16. Medtronic plc
  • 17.17. MJ Surgical
  • 17.18. Orthofix Medical Inc.
  • 17.19. Ossio, Inc.
  • 17.20. Parcus Medical LLC
  • 17.21. Rejoin Medical Device Co., Ltd.
  • 17.22. RTI Surgical, Inc.
  • 17.23. Smith & Nephew plc
  • 17.24. Stryker Corporation
  • 17.25. Tokyo Ohka Kogyo Co., Ltd.
  • 17.26. Wright Medical Group N.V.
  • 17.27. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY PEEK (POLYETHER ETHER KETONE), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY PEEK (POLYETHER ETHER KETONE), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY PEEK (POLYETHER ETHER KETONE), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY LABRAL REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY LABRAL REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY LABRAL REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ACADEMIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ACADEMIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 102. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)